Self-management in pediatric inflammatory bowel disease: A clinical report of the north american society for pediatric gastroenterology, hepatology, and nutrition

Journal of Pediatric Gastroenterology and Nutrition

Volumn 57, Issue 2, 2013, Pages 250-257

  Hommel, Kevin A ^a   Greenley, Rachel N ^b   Maddux, Michele Herzer ^c   Gray, Wendy N ^a   MacKner, Laura M ^d  

^a CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

^b ROSALIND FRANKLIN UNIVERSITY OF MEDICINE AND SCIENCE   (United States)

^c CHILDREN S MERCY HOSPITAL   (United States)

^d NATIONWIDE CHILDREN S HOSPITAL   (United States)

Author keywords

adherence; compliance; inflammatory bowel disease; psychosocial; self management; treatment

Indexed keywords

AMINOSALICYLIC ACID; AZATHIOPRINE; CALCIUM; CORTICOSTEROID; DRUG METABOLITE; IMMUNOMODULATING AGENT; IRON; MERCAPTOPURINE; MULTIVITAMIN; NON PRESCRIPTION DRUG;

ARTICLE; CHILDHOOD DISEASE; CLINICAL OBSERVATION; COGNITION; COMPARATIVE EFFECTIVENESS; CORTICOSTEROID THERAPY; DISEASE ACTIVITY; DRUG MONITORING; ENTERITIS; FAMILY; HEALTH BEHAVIOR; HEALTH CARE SYSTEM; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; MEDICAL SOCIETY; MENTAL HEALTH; PATIENT COMPLIANCE; PATIENT MONITORING; PHARMACEUTICAL CARE; PHYSICIAN; PREVALENCE; PRIORITY JOURNAL; SELF CARE; SOCIAL ASPECT; SOCIAL STATUS; TOTAL QUALITY MANAGEMENT;

CHILD; HUMANS; INFLAMMATORY BOWEL DISEASES; MEDICATION ADHERENCE; PEDIATRICS; SELF CARE;

EID: 84881028220     PISSN: 02772116     EISSN: 15364801     Source Type: Journal    
DOI: 10.1097/MPG.0b013e3182999b21     Document Type: Article

References (58)

1. Mackner LM, Crandall WV, Szigethy EM. Psychosocial functioning in pediatric inflammatory bowel disease. Inflamm Bowel Dis 2006; 12:239-44.
2. Crohn's and Colitis Foundation of America. About the epidemiology of IBD. http://www.ccfa.org/resources/epidemiology.html. Accessed May 30, 2013
3. Haynes RB. Introduction. In: Haynes RB, Taylor DW, Sackett DL, eds. Compliance in Health Care. Baltimore: Johns Hopkins University Press; 1979:1-7.
4. Modi AC, Pai AL, Hommel KA, et al. Pediatric self-management: a framework for research, practice, and policy. Pediatrics 2012;129: e473-85.
5. Schaefer J, Miller D, Goldstein M, et al. Partnering in Self-Management Support: A Toolkit for Clinicians. Cambridge, MA: Institute for Healthcare Improvement; 2009.
6. Cerveny P, Bortlik M, Kubena A, et al. Nonadherence in inflammatory bowel disease: results of factor analysis. Inflamm Bowel Dis 2007; 13:1244-9.
7. San Roman AL, Bermejo F, Carrera E, et al. Adherence to treatment in inflammatory bowel disease. Rev Esp Enferm Dig 2005;97:249-57.
8. Shale MJ, Riley SA. Studies of compliance with delayed-released mesalizaine therapy in patients with inflammatory bowel disease. Aliment Pharmacol Ther 2003;18:191-8.
9. Bernal I, Domenech E, Garcia-Planella E, et al. Medication-taking behavior in a cohort of patients with inflammatory bowel disease. Dig Dis Sci 2006;51:2165-9.
10. D'Inca R, Bertomoro P, Mazzocco K, et al. Risk factors for non-adherence to medication in inlammatory bowel disease patients. Aliment Pharmacol Ther 2008;27:166-72.
11. Ediger JP, Walker JR, Graff L, et al. Predictors of medication adherence in inflammatory bowel disease. Am J Gastroenterol 2007;102:1-10.
12. Greenley RN, Stephens M, Doughty A, et al. Barriers to adherence among adolescents with inflammatory bowel disease. Inflamm Bowel Dis 2010;16:36-41.
13. Schurman JV, Cushing CC, Carpenter E, et al. Volitional and accidental nonadherence to pediatric inflammatory bowel disease treatment plans: initial investigation of associations with quality of life and disease activity. J Pediatr Psychol 2011;36:116-25.
14. Hommel KA, Baldassano RN. Brief report: barriers to treatment adherence in pediatric inflammatory bowel disease. J Pediatr Psychol 2010;35:1005-10.
15. Oliva-Hemker MM, Abadom V, Cuffari C, et al. Nonadherence with thiopurine immunomodulator and mesalamine medications in children with Crohn disease. J Pediatr Gastroenterol Nutr 2007;44:180-4.
16. Ingerski LM, Baldassano RN, Denson LA, et al. Barriers to oral medication adherence for adolescents with inflammatory bowel disease. J Pediatr Psychol 2010;35:683-91.
17. Rapoff MA. Adherence to Pediatric Medical Regimens. 2nd ed. New York: Springer; 2010.
18. Holmbeck GN, Greenley RN, Franks EA. Developmental issues and considerations in child and adoelscents therapy: research and practice. In: Kazdin AE, Weisz JR, eds. Evidence-based Psychotherapies for Children and Adoelscents. New York: Guilford Press; 2003:21-41.
19. La Greca AM, Follansbee D, Sklyar JS. Developmental and behavioral aspects of diabetes management in youngsters. Child Health Care 1990;19:132-9.
20. Greenley RN, Stephens K, Nguyen E, et al. Vitamin and mineral supplement nonadherence in pediatric inflammatory bowel disease. Inflamm Bowel Dis 2012;18:1254-9.
21. Gray WN, Denson LA, Baldassano RN, et al. Treatment adherence in adolescents with inflammatory bowel disease: the collective impact of barriers to adherence and anxiety/depressive symptoms. J Pediatr Psychol 2012;37:282-91.
22. Mackner LM, Crandall WV. Oral medication adherence in pediatric inflammatory bowel disease. Inflamm Bowel Dis 2005;11:1006-12.
23. Greenley RN, Kunz JH, Biank V, et al. Identifying youth nonadherence in clinical settings: data-based recommendations for children and adolescents with inflammatory bowel disease. Inflamm Bowel Dis 2012;18:1254-9.
24. Reed-Knight B, Lewis JD, Blount RL. Association of disease, adolescent, and family factors with medication adherence in pediatric inflammatory bowel disease. J Pediatr Psychol 2010;36:308-17.
25. Nguyen E, Greenley RN, Kunz JH, et al. White Coat Adherence in Pediatric Inflammatory Bowel Disease. Milwaukee, WI: Midwest Regional Conference on Pediatric Psychology; 2012.
26. Litt IF, Cuskey WR. Satisfaction with health care. A predictor of adolescents' appointment keeping. J Adolesc Health Care 1984;5: 196-200.
27. Hazzard A, Hutchinson SJ, Krawiecki N. Factors related to adherence to medication regimens in pediatric seizure patients. J Pediatr Psychol 1990;15:543-55.
28. Robinson A, Bokemeyer B, Cripps S, et al. Towards better patient compliance in IBD: report of an international compliance consensus meeting. Gastroenterol Hepatol 2005;1:206-15.
29. Nguyen GC, VaVeist TA, Harris ML, et al. Patient trust-in-physician and race are predictors of adherence to medical management in inflammatory bowel disease. Inflamm Bowel Dis 2009;15:1233-9.
30. Sewitch MJ, Abrahamowicz M, Barkun A, et al. Patient nonadherence to medication in inflammatory bowel disease. Am J Gastroenterol 2003;98:1535-44.
31. Hommel KA, Davis CM, Baldassano RN. Objective versus subjective assessment of oral medication adherence in pediatric inflammatory bowel disease. Inflamm Bowel Dis 2009;15:589-93.
32. Bousvaros A, Sylvester F, Kugathasan S, et al. Challenges in pediatric inflammatory bowel disease. Inflamm Bowel Dis 2006;12:885-913.
33. Israel DM, Hassall E. Prolonged use of gastrostomy for enteral hyper-alimentation in children with Crohn's disease. Am J Gastroenterol 1995;90:1084-8.
34. Higgins PDR, Rubin DT, Kaulback K, et al. Systematic review: Impact of non-adherence to 5-aminosalicylic acid products on the frequency and cost of ulcerative colitis flares. Aliment Pharmacol Ther 2009;29:247-57.
35. Kane S, Huo D, Aikens J, et al. Medication nonadherence and the outcomes of patients with quiescent ulcerative colitis. Am J Med 2003;114:39-43.
36. Hommel KA, Davis CM, Baldassano RN. Medication adherence and quality of life in pediatric inflammatory bowel disease. J Pediatr Psychol 2008;33:867-74.
37. Zelikovsky N, Schast AP. Eliciting accurate reports of adherence in a clinical interview: development of the medical adherence measure. Pediatr Nurs 2008;34:141-6.
38. Morisky DE, Green LW, Levine DM. Concurrent and predictive validity of a self-reported measure of medication adherence. Med Care 1986;24:67-74.
39. Morisky DE, Ang A, Krousel-Wood M, et al. Predictive validity of a medication adherence measure for hypertension control. J Clin Hyper-tens 2008;10:348-54.
40. Trindade AJ, Ehrlich A, Kornbluth A, et al. Are your patients taking their medicine? Validation of a new adherence scale in patients with inflammatory bowel disease and comparison with physician perception of adherence. Inflamm Bowel Dis 2011;17:599-604.
41. Osterberg L, Blaschke T. Adherence to medication. N Engl J Med 2005;353:487-97.
42. Shemesh E, Shneider BL, Savitzky JK, et al. Medication adherence in pediatric and adolescent liver transplant recipients. Pediatrics 2004;113: 825-32.
43. Finney JW, Hook RJ, Friman PC, et al. The overestimation of adherence to pediatric medical regimens. Child Health Care 1993;22:297-304.
44. La Greca AM, Bearman KJ. Adherence to pediatric treatment regimens. In: Roberts MC, ed. Handbook of Pediatric Psychology. 3rd ed. New York: The Guilford Press; 2003:119-40.
45. Ingerski LM, Hente EA, Modi A, et al. Electronic measurement of medication adherence in pediatric chronic illness: a review of measures. J Pediatr 2011;159:528-34.
46. Lakatos PL. Prevalence, predictors, and clinical consequences of medical adherence in IBD: how to improve it? World J Gastroenterol 2009;15:4234-9.
47. Cramer JA, Scheyer RD, Mattson RH. Compliance declines between clinic visits. Arch Intern Med 1990;150:1509-10.
48. Drotar D, Crawford D, Bonner M. Collaborative decision making and treatment adherence promotion in the management of pediatric chronic illness. Patient Intell 2010;2:1-7.
49. Hommel KA, Denson LA, Baldassano RN. Oral medication adherence and disease severity in pediatric inflammatory bowel disease. Eur J Gastroenterol Hepatol 2011;23:250-4.
50. Kahana S, Drotar D, Frazier T. Meta-analysis of psychological interventions to promote adherence to treatment in pediatric chronic health conditions. J Pediatr Psychol 2008;33:590-611.
51. Hommel KA, Herzer M, Ingerski LM, et al. Individually-tailored treatment of medication nonadherence. J Pediatr Gastroenterol Nutr 2011;53:435-9.
52. Modi AC, Quittner AL. Barriers to treatment adherence for children with cystic fibrosis and asthma: What gets in the way? J Pediatr Psychol 2006;31:846-58.
53. McQuaid EL. Commentary: Integrating lessons from evidence-based assessment of adherence into clinical practice. J Pediatr Psychol 2008;33:937-8.
54. Drotar D. Promoting Adherence to Medical Treatment in Chronic Childhood Illness: Concepts, Methods, and Interventions. Mahwah, NJ: Lawrence Erlbaum Associates; 2000.
55. Mackner LM, Crandall WV. Psychological factors affecting pediatric inflammatory bowel disease. Curr Opin Pediatr 2007;19:548-52.
56. Lorig KR, Holman H. Self-management education: history, definition, outcomes, and mechanisms. Ann Behav Med 2003;26:1-7.
57. Holman H, Lorig K. Patient self-management: a key to effectiveness and efficiency in care of chronic disease. Public Health Rep 2004;119:239-43.
58. Huber M, Knottnerus JA, Green L, et al. How should we define health? BMJ 2011;343:d4163.